Profit Sheets

Solara Active Pharma shares tanks 20%, hits 52-week low on Q3 results

February 10, 2022 02:31 PM

Solara Active Pharma shares tanks 20%, hits 52-week low on Q3 results
The pharmaceutical company had posted a profit of Rs 65.78 crore in the year-ago quarter (Q3FY21).

Shares of Solara Active Pharma Sciences were locked at 20 per cent lower circuit limit at Rs 775.05, also its 52-week low, on the BSE on Thursday after the company reported a consolidated net loss of Rs 140 crore in December quarter (Q3FY22), due to lower revenue.

The pharmaceutical company had posted a profit of Rs 65.78 crore in the year-ago quarter (Q3FY21).

The Solara Active Pharma has corrected 58 per cent from its 52-week high level of Rs 1,859.30 touched on May 19, 2021. Till 09:33 am, around 55,000 shares changed had hands and there were pending sell orders for 770,000 shares on the NSE and BSE.

In Q3FY22, the company’s revenue declined 74 per cent sequentially and 76 per cent year-on-year (YoY) to Rs 105 crore. It reported operating loss of Rs 81.7 crore as against profit of Rs 88.5 crore in Q3FY21.

During the quarter, revenue from operations declined on account of continued demand softness of Ibuprofen & few other key products and delay in approval for Covld-19 products.

Also  Read : Stocks In the News: ACC, Tata Power Company, Power Grid, Nykaa, and others

Further, the Group also accounted for provision towards sales return to execute its strategy of shifting towards sales to direct customer by significantly limiting sales through channel.

The management said besides this one-off impact, “Solara’s Q3FY22 performance was muted mainly due to subdued regulated market demand and higher costs driven by volatile material pricing environment and increased logistics cost”.

That said, the management believes that the situation has bottomed out on the demand side, and the business would start seeing normalcy from the Q4FY22.

“We remain committed to delivering our long-term goals on growth and profitability, and we expect to bounce back from the second half of next fiscal. In the near term, we expect the topline trajectory to be back to pre-Q3 FY22 levels,” the management said.

Meanwhile, Solara announced that Bharath R Sesha has tendered his resignation as managing director & chief executive officer and director (MD & CEO) of the company to pursue interests outside the company. Rajesh Salwan, who currently is the executive vice chairman of the company, has been given the additional responsibility of MD & CEO, the company said.

Leave a comment

Your email address will not be published. Required fields are marked *


Intraday Tips
Stock Name Open Price Trend Details
Reliance 1930.10 Buy  Click Here
Asian Paints 2577.00 Buy  Click Here
HDFC 2448.00 Buy  Click Here
HDFCAMC 2790.00 Buy  Click Here
TCS 3120.00 Buy  Click Here


NSE Top Gainers/Losers
COMPANY LTP %CHNG VOLUME
ITC 253.75 1.83 1,26,68,576
M&M 807.10 1.73 48,32,584
JSWSTEEL 728.65 1.55 42,75,780
TATACONSUM 776.30 1.36 21,46,724
HINDUNILVR 2,043.00 1.34 16,38,568
COMPANY LTP %CHNG VOLUME
HINDALCO 569.90 -4.98 1,67,38,310
DIVISLAB 4,431.15 -2.37 3,48,495
APOLLOHOSP 4,525.45 -1.94 8,77,622
RELIANCE 2,634.00 -1.46 33,99,115
CIPLA 1,014.65 -1.39 12,17,592